Publication | Closed Access
An Employer-Based Cost-Benefit Analysis of a Novel Pharmacotherapy Agent for Smoking Cessation
44
Citations
14
References
2007
Year
The economic benefit of varenicline is improved over bupropion, despite the increased initial cost of varenicline.
| Year | Citations | |
|---|---|---|
Page 1
Page 1